Lewis B. Kinter

2.8k total citations
97 papers, 1.9k citations indexed

About

Lewis B. Kinter is a scholar working on Pulmonary and Respiratory Medicine, Social Psychology and Molecular Biology. According to data from OpenAlex, Lewis B. Kinter has authored 97 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 37 papers in Social Psychology and 21 papers in Molecular Biology. Recurrent topics in Lewis B. Kinter's work include Neuroendocrine regulation and behavior (37 papers), Electrolyte and hormonal disorders (35 papers) and Neonatal Respiratory Health Research (12 papers). Lewis B. Kinter is often cited by papers focused on Neuroendocrine regulation and behavior (37 papers), Electrolyte and hormonal disorders (35 papers) and Neonatal Respiratory Health Research (12 papers). Lewis B. Kinter collaborates with scholars based in United States, United Kingdom and Singapore. Lewis B. Kinter's co-authors include Klaas Kramer, William B. Kinter, Charles E. Stirling, Karl John Karnaky, Ruth Edwards, Walter Trizna, William F. Huffman, F L Stassen, Alan Bass and Reinier Beeuwkes and has published in prestigious journals such as The Journal of Cell Biology, Circulation Research and Environmental Health Perspectives.

In The Last Decade

Lewis B. Kinter

96 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lewis B. Kinter United States	21	490	342	285	240	234	97	1.9k
J. Ian Mason United Kingdom	32	1.0k 2.1×	120 0.4×	81 0.3×	71 0.3×	55 0.2×	87	3.1k
Kristen B. Eik‐Nes United States	35	915 1.9×	218 0.6×	171 0.6×	62 0.3×	62 0.3×	188	4.0k
Eric K. Birks United States	25	284 0.6×	290 0.8×	16 0.1×	177 0.7×	355 1.5×	59	2.5k
C.J. Kenyon United Kingdom	23	295 0.6×	188 0.5×	62 0.2×	98 0.4×	123 0.5×	68	1.6k
Jean Fiet France	35	1.1k 2.2×	592 1.7×	48 0.2×	74 0.3×	58 0.2×	170	3.4k
Philippe Poujeol France	30	1.5k 3.1×	308 0.9×	54 0.2×	81 0.3×	237 1.0×	99	3.0k
K. A. Munday United Kingdom	27	1.2k 2.4×	134 0.4×	34 0.1×	326 1.4×	273 1.2×	150	2.5k
Charles A. Strott United States	36	1.5k 3.0×	167 0.5×	89 0.3×	32 0.1×	55 0.2×	102	4.1k
Frank Wehner Germany	26	1.2k 2.5×	93 0.3×	32 0.1×	102 0.4×	90 0.4×	106	2.1k
Leo T. Samuels United States	34	872 1.8×	220 0.6×	77 0.3×	34 0.1×	82 0.4×	93	3.7k

Countries citing papers authored by Lewis B. Kinter

Since Specialization

Citations

This map shows the geographic impact of Lewis B. Kinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis B. Kinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis B. Kinter more than expected).

Fields of papers citing papers by Lewis B. Kinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis B. Kinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis B. Kinter. The network helps show where Lewis B. Kinter may publish in the future.

Co-authorship network of co-authors of Lewis B. Kinter

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis B. Kinter. A scholar is included among the top collaborators of Lewis B. Kinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis B. Kinter. Lewis B. Kinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yafei, J. D. Thurman, Lewis B. Kinter, Russell Bialecki, & J. Eric McDuffie. (2017). Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys. Toxicology and Applied Pharmacology. 336. 66–74. 11 indexed citations

Kinter, Lewis B. & David K. Johnson. (2015). A defense of 'risk-benefit' terminology. Lab Animal. 44(10). 403–407. 4 indexed citations

Bass, Alan, Hugo M. Vargas, Jean‐Pierre Valentin, et al.. (2011). Safety pharmacology in 2010 and beyond: Survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society. Journal of Pharmacological and Toxicological Methods. 64(1). 7–15. 8 indexed citations

Winter, Matthew J., Duane B. Huggett, Paul McCormack, et al.. (2011). In vivoandin vitroliver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta‐blocker propranolol. Environmental Toxicology. 27(10). 573–582. 26 indexed citations

Bass, Alan, Gordon F. Tomaselli, Roy Bullingham, & Lewis B. Kinter. (2005). Drugs effects on ventricular repolarization: A critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices. Journal of Pharmacological and Toxicological Methods. 52(1). 12–21. 29 indexed citations

Bass, Alan, Lewis B. Kinter, & Patricia B. Williams. (2004). Origins, practices and future of safety pharmacology. Journal of Pharmacological and Toxicological Methods. 49(3). 145–151. 50 indexed citations

Kinter, Lewis B. & Jean‐Pierre Valentin. (2002). Safety pharmacology and risk assessment. Fundamental and Clinical Pharmacology. 16(3). 175–182. 26 indexed citations

Bacon, Edward R., et al.. (2000). Pharmacokinetics and Hepatic Disposition of Bis[1-(ethoxycarbonyl)propyl]5-acetylamino-2,4,6-triiodoisophthalate in Rats and Isolated Perfused Rat Livers. Drug Metabolism and Disposition. 28(7). 731–736. 6 indexed citations

Kinter, Lewis B., S Caltabiano, & William F. Huffman. (1993). Anomalous antidiuretic activity of antidiuretic hormone antagonists. Biochemical Pharmacology. 45(9). 1731–1737. 16 indexed citations

10.

Mann, William A. & Lewis B. Kinter. (1993). Characterization of the renal handling of p-aminohippurate (PAH) in the beagle dog (Canis familiaris). General Pharmacology The Vascular System. 24(2). 367–372. 7 indexed citations

11.

Kinter, Lewis B., et al.. (1990). Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog. Chirality. 2(4). 219–225. 5 indexed citations

12.

Egan, J., et al.. (1989). Effect of a selective V1 vasopressin receptor antagonist on the sequelae of endotoxemia in the conscious rat.. PubMed. 29(2). 155–66. 3 indexed citations

13.

Brooks, David P., Paul F. Koster, Christine R. Albrightson, et al.. (1989). Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements. European Journal of Pharmacology. 160(1). 159–162. 7 indexed citations

14.

Uyehara, Catherine, S Caltabiano, Lewis B. Kinter, & M. Gellai. (1989). Noncyclic vasopressin analogs are effective diuretics in conscious rats.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 1128–1133. 1 indexed citations

15.

Huffman, William F., B Brickson, George Dytko, et al.. (1989). A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity. Journal of Medicinal Chemistry. 32(4). 880–884. 7 indexed citations

16.

Brooks, David P., Paul F. Koster, C R Albrightson-Winslow, et al.. (1988). SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).. PubMed. 245(1). 211–5. 16 indexed citations

17.

Moore, M. Lane, Christine R. Albrightson, B Brickson, et al.. (1988). Dicarbavasopressin antagonist analogs exhibit reduced in vivo agonist activity. Journal of Medicinal Chemistry. 31(8). 1487–1489. 7 indexed citations

18.

Sarkar, Susanta K., George Holland, Robert E. Lenkinski, Mark A. Mattingly, & Lewis B. Kinter. (1988). Renal imaging studies at 1.5 and 9.4 T: Effects of diuretics. Magnetic Resonance in Medicine. 7(1). 117–124. 6 indexed citations

19.

Ali, Fadia E., William F. Huffman, Lewis B. Kinter, et al.. (1987). Potent vasopressin antagonist modified at the carboxy-terminal tripeptide tail. Journal of Medicinal Chemistry. 30(12). 2291–2294. 2 indexed citations

20.

Kinter, Lewis B., et al.. (1982). The Renin Angiotensin System in Conscious Brattleboro Strain Rats. Kidney & Blood Pressure Research. 5(6). 278–285. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact